Glycosmedia

Diabetes News Service

  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Category: Treatment


Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis

April 19th 2018

Artificial pancreas systems are an efficacious and safe approach for treating outpatients with type 1 diabetes. The main limitations of current research evidence on artificial pancreas systems are related to inconsistency in outcome reporting, small sample size, and short follow-up duration of individual trials (BMJ)

Categories: News, Treatment
Tags: artificial pancreas, Type 1 Diabetes

Categories: Treatment
Tags: artificial pancreas, Type 1 Diabetes

Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus

April 17th 2018

A Guidance Statement Update From the American College of Physicians

Categories: News, Treatment
Tags: HbA1c, Type 2 Diabetes

Categories: Treatment
Tags: HbA1c, Type 2 Diabetes

Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?

April 16th 2018

We consider the benefits and limitations of these medications based on data from randomized clinical trials and discuss how they may address barriers to treatment intensification  (Clinical Diabetes)

Categories: News, Treatment
Tags: GLP1, insulin, Type 2 Diabetes

Categories: Treatment
Tags: GLP1, insulin, Type 2 Diabetes

Gender differences in the evaluation of care for patients with type 2 diabetes: a cross-sectional study (ZODIAC-52)

April 13th 2018

Only a few factors were found to be associated with patients’ evaluation of care for men and women with T2D. Taken together, these factors explained only a small part of the variance of the EUROPEP scores. This explained variance was largely attributable to the location where the questionnaire was completed (BMC Health Services Research)

Categories: News, Treatment
Tags: gender, Type 2 Diabetes

Categories: Treatment
Tags: gender, Type 2 Diabetes

Development and validation of a scoring system for prediction of insulin requirement for optimal control of blood glucose during glucocorticoid treatments

April 3rd 2018

The scoring system is a valid and reliable tool to predict insulin requirements in advance during GC treatment (Diabetes Research and Clinical Practice)

Categories: News, Treatment
Tags: glucocorticoid, insulin, scoring

Categories: Treatment
Tags: glucocorticoid, insulin, scoring

Structured education using Dose Adjustment for Normal Eating (DAFNE) reduces long‐term HbA1c and HbA1c variability

April 2nd 2018

The data confirm that DAFNE participation improves glycaemic control in Type 1 diabetes with benefits being sustained for 5 years. This study is the first to demonstrate reduced HbA1c variability after completion of structured education. This is new evidence of the beneficial impact of DAFNE on glycaemic profile (Diabetic Medicine)

Categories: News, Treatment
Tags: DAFNE, HbA1c

Categories: Treatment
Tags: DAFNE, HbA1c

Impact of drugs on hypoglycaemia in hospitalised patients

March 19th 2018

The relationship between hypoglycaemia and polypharmacy reinforces the advice to limit polymedication as much as possible, especially in elderly patients. This result underlines the potential involvement of clinical pharmacists with the aim to reduce the risk of hypoglycaemia during hospitalisation (BMJ)

Categories: News, Treatment
Tags: hypoglycemia, inpatient, polypharmacy

Categories: Treatment
Tags: hypoglycemia, inpatient, polypharmacy

Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus

March 6th 2018

Guidance Statement Update From the American College of Physicians (Annals of Internal Medicine)

Categories: News, Treatment
Tags: glycaemic control, HbA1c, Type 2 Diabetes

Categories: Treatment
Tags: glycaemic control, HbA1c, Type 2 Diabetes

Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes

February 23rd 2018

This expert panel included general practitioners (GPs), nurses, nurse practitioners, endocrinologists, dieticians, pharmacists, and a psychologist. This article summarizes the panel recommendations (Diabetes Therapy)

Categories: News, Treatment
Tags: insulin, Type 2 Diabetes

Categories: Treatment
Tags: insulin, Type 2 Diabetes

Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy

February 22nd 2018

Introducing basal insulin analogues in persons with T2DM previously inadequately controlled on other insulin types can significantly improve glycemic control and reduce the risk of hypoglycemia, without adversely affecting body weight (Diabetes Therapy)

Categories: News, Treatment
Tags: insulin, Type 2 Diabetes

Categories: Treatment
Tags: insulin, Type 2 Diabetes

Diabetes in the Elderly

February 19th 2018

This review takes a practical approach to the assessment, nursing care, and medical treatment of diabetes in the elderly. It highlights major challenges and suggests solutions to these commonly encountered clinical problems  (Diabetes Therapy)

Categories: News, Treatment
Tags: elderly

Categories: Treatment
Tags: elderly

Integrating diabetes evidence into practice

February 16th 2018

Challenges and opportunities to bridge the gaps (IDF)

Categories: News, Treatment
Tags: IDF

Categories: Treatment
Tags: IDF

Control of glycemia and blood pressure in British adults with diabetes mellitus and subsequent therapy choices: a comparison across health states

February 13th 2018

Glycemic and hypertensive control exhibited statistically significant but small magnitude differences across frailty states. Medication deintensification was uncommon, even in frail patients below SBP and HbA1C targets. SBP levels were more likely to be outside recommended treatment ranges than glycemic levels (Cardiovascular Diabetology)

Categories: News, Treatment
Tags: blood pressure, glycaemic control

Categories: Treatment
Tags: blood pressure, glycaemic control

Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study

February 8th 2018

These results demonstrate that a novel metabolic and continuous remote care model can support adults with T2D to safely improve HbA1c, weight, and other biomarkers while reducing diabetes medication use  (Diabetes Therapy)

Categories: News, Treatment
Tags: carbohydrate, Type 2 Diabetes

Categories: Treatment
Tags: carbohydrate, Type 2 Diabetes

Long-term effects on glycaemic control and β-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes

February 6th 2018

The findings indicate that outpatient clinic-based IIT to ensure euglycaemia in newly diagnosed patients with T2DM might be an effective initial therapeutic option for improvements in β-cell function and glycaemic control over the long term, without serious adverse events (Diabetes, Obesity and Metabolism)

Categories: News, Treatment
Tags: Type 2 Diabetes, β-cell

Categories: Treatment
Tags: Type 2 Diabetes, β-cell

A 2-year Trial of Intermittent Insulin Therapy versus Metformin for the Preservation of Beta-cell Function after Initial Short-term Intensive Insulin Induction in early Type 2 Diabetes

January 29th 2018

Following induction IIT, metformin was superior to intermittent IIT for maintaining beta-cell function and glycemic control over 2-years. The strategy of induction and maintenance therapy to preserve beta-cell function warrants exploration in early T2DM (Diabetes, Obesity and Metabolism)

Categories: News, Treatment
Tags: beta cell, Insulin resistance, metformin, Type 2 Diabetes

Categories: Treatment
Tags: beta cell, Insulin resistance, metformin, Type 2 Diabetes

Individualised treatment targets in patients with type-2 diabetes and hypertension

January 23rd 2018

Achievement of treatment targets was poor, leaving many patients with sub-optimal blood glucose levels. The apparent reluctance of physicians to intensify antidiabetic drug therapy is alarming, especially considering the evidence pointing to an association of hyperglycaemia and microvascular complications in patients with T2DM (Cardiovascular Diabetology)

Categories: News, Treatment
Tags: Type 2 Diabetes

Categories: Treatment
Tags: Type 2 Diabetes

Weight-based carbohydrate treatment of hypoglycaemia in people with Type 1 diabetes using insulin pump therapy: a randomized crossover clinical trial

January 3rd 2018

Weight-based treatment using 0.3 g/kg glucose was more effective for symptomatic hypoglycaemia in children and adults with Type 1 diabetes who were using continuous subcutaneous insulin infusion than treatment based on current international recommendations (Diabetic Medicine)

Categories: News, Treatment
Tags: carbohydrate, hypoglycemia, Type 1 Diabetes

Categories: Treatment
Tags: carbohydrate, hypoglycemia, Type 1 Diabetes

15. Diabetes Advocacy: Standards of Medical Care in Diabetes—2018

December 17th 2017

American Diabetes Association

Categories: News, Treatment
Tags: ADA

Categories: Treatment
Tags: ADA

14. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2018

December 17th 2017

American Diabetes Association

Categories: News, Treatment
Tags: ADA

Categories: Treatment
Tags: ADA
  • 1
  • 2
  • 3
  • …
  • 18
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsor

Sanofi Diabetes

Gold Sponsors

MSDNovo NordiskBoehringer Ingelheim LillyNapp DiabetesAstraZeneca

Silver Sponsors

Abbott Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI cancer CGM dapagliflozin DPP4 Empagliflozin Europe exenatide exercise GLP1 glucagon glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis liraglutide metformin microbiota mortality NICE OGTT pioglitazone pregnancy retinopathy RYGB semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Share Glycosmedia

Follow us on Twitter

My Tweets

Glycosmedia App

mobileA Glycosmedia iPhone/iPad App is available FREE from the iTunes store.


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com


HONcode Standard

HONConduct783211_s2This site complies with the HONcode standard for trustworthy health information: verify here.

Copyright © 2018 Glycosmedia Partnership